Advisor Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $808K | Buy |
9,565
+446
| +5% | +$37.7K | 0.01% | 1346 |
|
|
2019
Q3 | $614K | Buy |
9,119
+1,885
| +26% | +$127K | ﹤0.01% | 1462 |
|
|
2019
Q2 | $619K | Buy |
7,234
+565
| +8% | +$48.3K | ﹤0.01% | 1464 |
|
|
2019
Q1 | $592K | Buy |
6,669
+551
| +9% | +$48.9K | ﹤0.01% | 1468 |
|
|
2018
Q4 | $521K | Buy |
6,118
+1,128
| +23% | +$96.1K | 0.01% | 1374 |
|
|
2018
Q3 | $483K | Buy |
4,990
+1,520
| +44% | +$147K | ﹤0.01% | 1498 |
|
|
2018
Q2 | $327K | Buy |
3,470
+1,680
| +94% | +$158K | ﹤0.01% | 1628 |
|
|
2018
Q1 | $145K | Sell |
1,790
-660
| -27% | -$53.5K | ﹤0.01% | 2235 |
|
|
2017
Q4 | $219K | Sell |
2,450
-97
| -4% | -$8.67K | ﹤0.01% | 1919 |
|
|
2017
Q3 | $237K | Sell |
2,547
-185
| -7% | -$17.2K | ﹤0.01% | 1726 |
|
|
2017
Q2 | $247K | Sell |
2,732
-361
| -12% | -$32.6K | ﹤0.01% | 1628 |
|
|
2017
Q1 | $270K | Sell |
3,093
-488
| -14% | -$42.6K | 0.01% | 1452 |
|
|
2016
Q4 | $298K | Buy |
3,581
+309
| +9% | +$25.7K | 0.01% | 1306 |
|
|
2016
Q3 | $304K | Buy |
3,272
+1,247
| +62% | +$116K | 0.01% | 1263 |
|
|
2016
Q2 | $155K | Buy |
+2,025
| New | +$155K | ﹤0.01% | 1625 |
|